Keros Therapeutics, Inc. · NASDAQ:KROS

Farzan Nima sold 2,625 Keros Therapeutics, Inc. shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 8, 2026

On Jun 4, 2026, Farzan Nima (Director) sold 2,625 Keros Therapeutics, Inc. shares at US$10.73 for US$28,166 under a trading plan, leaving 9,767 shares. Filed Jun 8, 2026 (Form 4).

Sold
2,625 shares
Price
US$10.73
Value
US$28,166
Holding after
9,767 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockSale2,625US$10.739,767Direct

Source

View original at SEC

Related